AstraZeneca’s Q1 revenue down by 4% to $10.88B

AstraZeneca PLC announced on Thursday that its revenue in the first quarter of the fiscal year 2023 saw an annual decline of 4% in actual terms to stand at $10.88 billion. Excluding COVID-19 medicines…